Y-mAbs Therapeutics New Drug Application Gets FDA Clearance

By Denny Jacob Y-mAbs Therapeutics' investigational new drug application for CD38-SADA was cleared by the Food and Drug Administration. The commercial-stage...

Related Keywords

Denny Jacob ,Drug Administration ,Abs Therapeutic ,Chief Executive Thomas Gad ,Article Normal ,Pharmaceuticals ,Cancer Drugs ,Healthcare Life Sciences ,Specialized Drugs Medications ,Synd ,Y Mabs Therapeutics ,Kymab ,Us9842411095 ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,